1、November 2025Third Quarter 2025 Financial Results and Recent Corporate Updates Forward-Looking StatementsThis presentation contains forward-looking statements,including statements relating to our strategy and plans;potential of and expectations for our business,commercial products,and pipeline progr

2、ams;our goals,objectives,and priorities and our expectations under our growth strategy(including our expectations regarding our commercial products and launches,clinical stage products,revenue growth/CAGR,profitability and timeline to profitability,operating margins,and cash flow);the peak sales pot

3、ential of our programs;capital allocation and investment strategy;clinical development programs and related clinical trials;expected timing and results of clinical trial data,data readouts,and presentations;risks and uncertainties associated with drug development,commercialization and outreach;regul

4、atory discussions,submissions,filings,and approvals and the timing and scope thereof;the potential benefits,safety,and efficacy of our products and product candidates and those of our collaboration partners;the anticipated benefits and potential of investments,collaborations,and business development

5、 activities;the potential market opportunities of,and estimated addressable markets for,our drug candidates;our future financial and operating results;and financial guidance.All statements,other than statements of historical fact,included in this presentation are forward-looking statements,and can b

6、e identified by words such as“aim,”“anticipate,”“believe,”“continue,”“could,”“estimate,”“expect,”“forecast,”“goal,”“intend,”“may,”“plan,”“possible,”“potential,”“target,”“will,”“would,”and other similar expressions.Such statements constitute forward-looking statements within the meaning of U.S.federa